Pediatric Miller Fisher Syndrome; Characteristic Presentation and Comparison with Adult Miller Fisher Syndrome.
Miller Fisher syndrome
acute inflammatory demyelinating polyneuropathy
antiganglioside antibodies
ophthalmoplegia
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Dec 2020
03 Dec 2020
Historique:
received:
05
10
2020
revised:
18
11
2020
accepted:
02
12
2020
entrez:
8
12
2020
pubmed:
9
12
2020
medline:
9
12
2020
Statut:
epublish
Résumé
We aimed to investigate the characteristic presentation of Miller Fisher syndrome (MFS) in pediatrics and compare it with that in adults. We performed a retrospective review of medical records, laboratory findings, and disease course of pediatric MFS. The data were compared with those of adult MFS, and literature review was done. Unpaired and paired comparisons between groups were made using Wilcoxon rank-sum and signed-rank tests, respectively. Median age for pediatric MFS was 9.8 ± 6.5 years. There were 5 (45.5%) male and 6 (54.5%) female patients. All patients had preceding infection. Two patients (22.2%) had tested positive for anti-GQ1b antibody. Ten patients (90.1%) were treated with intravenous immunoglobulin, and 2 (18.2%) also received intravenous methylprednisolone. Within one month, 8 (72.7%) patients showed recovery, and all 11 (100%) recovered fully within 3 months. Further, the pediatric group had higher frequency of unilateral involvement of ophthalmoplegia, ataxia, and autonomic symptoms but lower antiganglioside antibody positivity and manifestations of areflexia than the adult group. Neuro-ophthalmic manifestations and disease course of pediatric MFS were similar to those of adult MFS as stated in the literature. However, the presence of autonomic symptoms was higher and anti-GQ1b antibody positivity was lower in pediatric MFS than in adult MFS.
Sections du résumé
BACKGROUND
BACKGROUND
We aimed to investigate the characteristic presentation of Miller Fisher syndrome (MFS) in pediatrics and compare it with that in adults.
METHODS
METHODS
We performed a retrospective review of medical records, laboratory findings, and disease course of pediatric MFS. The data were compared with those of adult MFS, and literature review was done. Unpaired and paired comparisons between groups were made using Wilcoxon rank-sum and signed-rank tests, respectively.
RESULTS
RESULTS
Median age for pediatric MFS was 9.8 ± 6.5 years. There were 5 (45.5%) male and 6 (54.5%) female patients. All patients had preceding infection. Two patients (22.2%) had tested positive for anti-GQ1b antibody. Ten patients (90.1%) were treated with intravenous immunoglobulin, and 2 (18.2%) also received intravenous methylprednisolone. Within one month, 8 (72.7%) patients showed recovery, and all 11 (100%) recovered fully within 3 months. Further, the pediatric group had higher frequency of unilateral involvement of ophthalmoplegia, ataxia, and autonomic symptoms but lower antiganglioside antibody positivity and manifestations of areflexia than the adult group.
CONCLUSIONS
CONCLUSIONS
Neuro-ophthalmic manifestations and disease course of pediatric MFS were similar to those of adult MFS as stated in the literature. However, the presence of autonomic symptoms was higher and anti-GQ1b antibody positivity was lower in pediatric MFS than in adult MFS.
Identifiants
pubmed: 33287444
pii: jcm9123930
doi: 10.3390/jcm9123930
pmc: PMC7761853
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Clin Neurosci. 2009 Dec;16(12):1698-9
pubmed: 19846311
Childs Nerv Syst. 1996 Sep;12(9):559-61
pubmed: 8906374
J Clin Neurosci. 2010 Mar;17(3):410-1
pubmed: 20071180
J Child Neurol. 2007 Jan;22(1):71-3
pubmed: 17608309
Pediatr Neurol. 2002 Mar;26(3):228-30
pubmed: 11955933
Acta Paediatr Taiwan. 2004 May-Jun;45(3):168-70
pubmed: 15493737
Pediatr Neurol. 2001 Jul;25(1):71-4
pubmed: 11483401
Child Neurol Open. 2019 Jun 16;6:2329048X19856778
pubmed: 31259196
Rev Neurol. 2006 Jan 16-31;42(2):85-90
pubmed: 16450322
Eur J Neurol. 2016 Jun;23(6):1058-63
pubmed: 26969889
Pediatr Neurol. 2003 Oct;29(4):349-50
pubmed: 14643401
Neuroepidemiology. 2009;32(2):150-63
pubmed: 19088488
Pediatr Neurol. 2016 Oct;63:73-75
pubmed: 27460528
N Engl J Med. 1956 Jul 12;255(2):57-65
pubmed: 13334797
J Paediatr Child Health. 2002 Aug;38(4):414-6
pubmed: 12174009
J Clin Neuroophthalmol. 1992 Mar;12(1):57-63
pubmed: 1532603
Childs Nerv Syst. 2005 Jun;21(6):473-6
pubmed: 15830202
Neurology. 2005 May 10;64(9):1605-11
pubmed: 15883324
Pediatr Int. 1999 Dec;41(6):685-8
pubmed: 10618891
Neurology. 1993 Oct;43(10):1911-7
pubmed: 8413947
Pediatr Neurol. 2009 Dec;41(6):451-2
pubmed: 19931169
J Clin Neurosci. 2017 May;39:63-67
pubmed: 28209311
Brain. 2008 May;131(Pt 5):1197-208
pubmed: 18184663
J Neurol. 2012 Jul;259(7):1366-74
pubmed: 22218648
Clin Pediatr (Phila). 1993 Jun;32(6):372-5
pubmed: 8344052
Pediatr Neurol. 1998 Jan;18(1):73-5
pubmed: 9492097
J Child Neurol. 2011 May;26(5):645-8
pubmed: 21325125
Medicine (Baltimore). 2019 Oct;98(41):e17500
pubmed: 31593118
Eur J Paediatr Neurol. 2017 Jul;21(4):654-660
pubmed: 28461111
Turk J Pediatr. 2013 Mar-Apr;55(2):235-6
pubmed: 24192691
J Neuroimmunol. 2004 Mar;148(1-2):200-5
pubmed: 14975602
J Neurol Sci. 2003 Jun 15;210(1-2):99-103
pubmed: 12736097
Neuroophthalmology. 2016 Jun 8;40(4):197-200
pubmed: 27928406
Neurology. 2001 Apr 24;56(8):1104-6
pubmed: 11320188
J Neurol. 2008 May;255(5):674-82
pubmed: 18274803
J Pediatr Ophthalmol Strabismus. 2008 Jul-Aug;45(4):245-6
pubmed: 18705624
Int Ophthalmol. 2018 Apr;38(2):837-839
pubmed: 28397145
Pediatrics. 2018 Mar;141(3):
pubmed: 29437883
Brain Dev. 1997 Apr;19(3):197-204
pubmed: 9134191
Brain Dev. 2002 Mar;24(2):98-101
pubmed: 11891101
Neurol Sci. 2013 Sep;34(9):1689-90
pubmed: 23196382
Indian J Pediatr. 2015 Feb;82(2):192-4
pubmed: 24997143
J Neuroimmunol. 2019 May 15;330:170-173
pubmed: 30642576
Eur J Paediatr Neurol. 2016 May;20(3):439-43
pubmed: 26924168
Pediatr Rev. 2018 Jan;39(1):39
pubmed: 29292287
J Peripher Nerv Syst. 2015 Mar;20(1):47-51
pubmed: 25640907
Turk J Pediatr. 2019;61(5):794-797
pubmed: 32105016
Turk J Pediatr. 2010 May-Jun;52(3):317-20
pubmed: 20718193
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):50-5
pubmed: 11118247
Eur J Paediatr Neurol. 2018 Jan;22(1):213-214
pubmed: 28967628
Brain Dev. 1993 May-Jun;15(3):231-3
pubmed: 8214351
Brain Dev. 2012 Apr;34(4):329-32
pubmed: 21742448
Neurology. 2003 May 13;60(9):1514-8
pubmed: 12743241
Handb Clin Neurol. 2017;146:125-138
pubmed: 29110767
J Child Neurol. 2012 Apr;27(4):521-2
pubmed: 21968982
Clin Pediatr (Phila). 1993 Nov;32(11):685-7
pubmed: 8299301
J Neuroimmunol. 2009 Oct 30;215(1-2):1-9
pubmed: 19643503
J Pediatr. 1970 Nov;77(5):868-70
pubmed: 5504080
Can J Ophthalmol. 2002 Oct;37(6):352-7; quiz 358
pubmed: 12422918
Pediatr Neurol. 2010 Feb;42(2):147-50
pubmed: 20117755
Nat Rev Neurol. 2014 Sep;10(9):537-44
pubmed: 25072194
Pediatr Neurol. 2012 Sep;47(3):213-5
pubmed: 22883289
Pediatr Neurol. 2014 Mar;50(3):269-71
pubmed: 24321544
Turk J Pediatr. 2007 Jan-Mar;49(1):109-12
pubmed: 17479657
Neurol Sci. 2019 Jan;40(1):67-73
pubmed: 30232672